Atherosclerosis

Imagine that you are one of 20 separate research teams that have been invited to submit a
proposal for $100,000 start-up funding by a venture-capital group to investigate a pharmacological
treatment for Atherosclerosis of your choosing.
Using your understanding of the hallmarks of Atherosclerosis and your independent research of the
literature, each member of the group is to prepare a short written proposal of a novel
pharmacological agent for the treatment of Atherosclerosis. The written proposal must follow the
structure and word limits of the provided pro forma. You should develop a brief case for why your
agent should be shortlisted for consideration by the venture-capital board of directors for funding.
Your case should identify which hallmark/hallmarks of Atherosclerosis are targeted, the mechanism
of drug action, and why your drug is worthy of further development.